Outcomes of two kinds of 3CLpro inhibitors in delayed treatment of COVID-19 patients with diabetes - Vienna 2024

After the storm: COVID-19 in 2024

Chair(s): Thomas Wilkinson, Anna Freeman

Session type: Poster session

Outcomes of two kinds of 3CLpro inhibitors in delayed treatment of COVID-19 patients with diabetes

qiongjiao wang

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Long COVID: A risk factor for anxiety, depression, and suicidality?

Neslihan ?z?elik

Poster

Abstract

Comparison of RSV, influenza and COVID-19 clinical characteristics in hospitalized adults in ValladolidSpain, 20102022

Eleftherios Markatis

Poster

Abstract

Air Pollution and post-acute sequelae of Covid-19: a multicentric study based on the EuCARE Project

Andr Almeida

Poster

Abstract

Persistent SARS-CoV-2 infection: the aftermath of the pandemic.

Stylianos Loukides

Poster

Abstract

The impact of COVID-19 infection on eosinophil dynamics

Maral Ranjbar

Poster

Abstract

Efficacy of Oral 20-hydroxyecdysone (20E) in adults with severe COVID-19

Capucine Morelot-panzini

Poster

Abstract

Skin conductance as indicator of relaxation capacity in patients with and without post-traumatic stress symptoms due to COVID-19 hospitalization

Michelle Iran Aboyte Pedroza

Abstract

Cytokines profile in COVID-19 patients during and following hospitalization

Dan Padawer

Poster

Abstract

The Impact of Early Antibiotic Use on Clinical Outcomes of Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis.

Yishan Duan

Abstract

Short- and long-term effects of imatinib in patients hospitalised for COVID-19: A randomised trial

Alex Halme

Poster

Abstract

Muscle Mass and COVID-19: Exploring the Prognostic Value of Sarcopenia through Psoas Volume Analysis using Artificial Intelligence Technology

Yoshitaka Wakabayashi

Poster

Abstract

Influence of demographics and dosing on COVID-19 outcomes and Favipiravir efficacy

Rebecca Wawman

Poster

Abstract

The early impact of COVID-19 vaccines on major events in pulmonary, cardiac, and thromboembolic disease: a nationwide retrospective cohort study

Myeong Geun Choi

Poster

Abstract

Retrospective analysis on Nirmatrelvir versus Simnotrelvir for adults with moderate to severe COVID-19.

Ling Liu

Abstract

Inhaled Aviptadil is a new hope for recovery of lung damage due to COVID-19

Dorina Rama Esendagli

Poster

Abstract

Clinical analysis of 6 patients with severe COVID-19 pneumonia who underwent pathological autopsy

Manabu Suzuki

Poster

Abstract

Outcomes of two kinds of 3CLpro inhibitors in delayed treatment of COVID-19 patients with diabetes

Qiongjiao Wang

Abstract

Greater COVID-19-related healthcare utilisation with multimorbidity versus single or immunocompromised conditions

Irini Zografaki

Poster

Abstract

Transaminiases and their association with disease severity and mortality in patients with Corona Virus Disease (COVID-19) in a tertiary hospital in the Philippines

Joni Ranada-camaquin

Abstract

A perspective on COVID-19 hospitalised patients across Europe: data from the END-COVID CRC

Mattia Nigro

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}